SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Supergen (supg)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: r g potgieser who wrote (78)5/18/1999 3:33:00 PM
From: Russian Bear  Read Replies (2) of 124
 
RG,

I do not see any similarity between the two.

ENMD was reported to have found the cure for cancer... maybe... someday... in mice, anyway... sort of...

SUPG, in contrast, gives every indication of having a real, and much needed, drug in PIII development. Pancreatic cancer is a disease with no effective treatment option. RFS2000 is an excellent bet (IMO) to relegate Gemzar to footnote status in the treatment of this disease. That said, the stock was certainly a better bargain at 9 than it is currently, at 18.

About the only similarity between the two companies is the penchant for aggressive self-promotion that appears to be common to both.

Good luck,
RB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext